Prevention & lipidsMeta-analysis

Use of Coronary Artery Calcium Scoring in Individuals With Elevated Lipoprotein(a)

J Am Coll CardiolPublished

  • Pooled analysis of prospective cohort studies
  • 4 US-based prospective cohorts
  • multivariable Cox regression

Authors' conclusion

Elevated Lp(a) is associated with higher relative risk across CAC strata, including CAC of 0. Among individuals with CAC of 0, absolute event rates remain low even when Lp(a) is elevated.

Study context

Population
Participants without known atherosclerotic cardiovascular disease (ASCVD) with baseline Lp(a) and coronary artery calcium (CAC) measurements1,569 ASCVD events
Participants
11,319 participants
Comparison
Lp >50 mg/dL vs ≤50 mg/dL across CAC strata
Outcome
Incident ASCVD (MI, stroke, coronary revascularization)
Follow-up
14.8 year mean

Pooled result

As reported in the abstract

Incident ASCVD
Each group vs Lp(a) ≤50 mg/dLHazard ratio (95% CI)
Lp(a) >50 mg/dLindependent of CAC
1.24(1.09–1.41)
CAC >0independent of Lp(a)
2.44(2.14–2.77)

Further pooled results

OutcomeLp(a) >50 mg/dLLp(a) ≤50 mg/dLHR (95% CI)
Incident ASCVD, CAC = 0 (subgroup)4.9 /1,000 person-years3.8 /1,000 person-years1.28 (1.01–1.60)
Incident ASCVD, CAC >0 (subgroup)21.2 /1,000 person-years18.2 /1,000 person-years3.03 (2.52–3.64)
Incident ASCVD, CAC ≥300 and Lp(a) >50 mg/dL · greatest risk6.12 (4.80–7.81)

By age and sex

Consistent results by age and sex; greater absolute risk in >50 years and men

Original publication

Use of Coronary Artery Calcium Scoring in Individuals With Elevated Lipoprotein(a). J Am Coll Cardiol. Published 16 March 2026. doi:10.1016/j.jacc.2026.02.5067

Summarised from the published abstract; every number is checked against it